Atrium Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/08/2026 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 13/08/2026 |
|---|---|---|---|---|
| $3 | $20 | $3.8 | $1.6 | |
| −$20 | −$17 | −$13 | −$7.4 | |
| −$1.18 | −$0.97 | −$0.75 | −$0.44 | |
| 17 | 17 | 17 | 17 |
Trend